Chronos CEO, Dr Huw Jones has been awarded best CEO in the European drug discovery industry by online and print magazine European CEO. Read the press release.
Dr Schulz-Utermoehl has over 17 years’ experience in the pharmaceutical industry, spanning early and late-stage discovery research and pre-clinical development. He and Dr Fraser Murray will be [...]
Dr Murray brings more than 20 years’ of drug discovery and early development experience across a range of therapeutic areas, including neurodegeneration, psychiatry, inflammation and [...]
Dr Kevin Thompson, an experienced biotech executive in both screening and neuroscience, joins as Director, Chronoscreen™. Kevin has over 20 years’ experience of drug screening and [...]